Energie & Umwelt · 20.2.20191 Min. Lesezeit
SHINE Medical Isotope Production Facility; Consideration of Approval of Transfer of License and Conforming Amendment
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The U.S. Nuclear Regulatory Commission (NRC) received and is considering approval of an application filed by SHINE Medical Technologies, Inc. (SHINE) on December 11, 2018. The application seeks NRC approval of the indirect transfer of Construction Permit No. CPMIF- 001 for the SHINE Medical Isotope Production Facility, currently held by SHINE. The indirect transfer will result from the establishment of a holding company, Illuminated Holdings, Inc. (Illuminated). The NRC is also considering amending Construction Permit No. CPMIF-001 for administrative purposes to reflect the proposed transfer. The application contains sensitive unclassified non-safeguards information (SUNSI).